TGM2 and rheumatoid arthritis: In RA, sarsasapogenin (Sar) has the potential to reduce the m6A methylation of TGM2 mRNA, thus contributing to the positive effects of Sar in RA-FLS cell cycle arrest and apoptosis, thus ameliorating RA progression [140].